My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Castle Biosciences, Inc. - Common stock (NQ:CSTL)

32.34 -0.03 (-0.09%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Castle Biosciences, Inc. - Common stock

< Previous 1 2 3 4 Next >

Dow Drops Over 100 Points; Crude Oil Rises ↗

June 05, 2023

U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Monday. The Dow traded down 0.33% to 33,651.23 while the NASDAQ rose 0.30% to 13,279.88. The S&P 500, also...

Via Benzinga

7 Analysts Have This to Say About Castle Biosciences ↗

June 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 05, 2023

Via Benzinga

Dow Drops Triple Digits; S&P 500, Nasdaq Extend Highs ↗

June 05, 2023

Via Talk Markets

Stocks That Hit 52-Week Lows On Monday ↗

June 05, 2023

Monday's session saw 41 companies set new 52-week lows.

Via Benzinga

Why Shares of Castle Biosciences Slumped This Week ↗

June 02, 2023

Investors were unimpressed by the company's study regarding its IDgenetix test.

Via The Motley Fool

Looking Into Castle Biosciences's Return On Capital Employed ↗

May 11, 2023

Via Benzinga

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 05, 2023

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.

Via Benzinga

Nasdaq Rises 70 Points; ISM Services PMI Drops In May ↗

June 05, 2023

U.S. stocks traded mixed midway through trading, with Nasdaq Composite gaining around 70 points on Monday. The Dow traded down 0.21% to 33,691.13 while the NASDAQ rose 0.54% to 13,312.65. The S&P 500,...

Via Benzinga

Analyst Expectations for Castle Biosciences's Future ↗

May 04, 2023

Via Benzinga

Looking Into Castle Biosciences's Return On Capital Employed ↗

November 16, 2022

Via Benzinga

Castle Biosciences: Q2 Earnings Insights ↗

August 08, 2022

Castle Biosciences (NASDAQ:CSTL) reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday ↗

June 05, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Mixed; SAIC Posts Upbeat Results ↗

June 05, 2023

U.S. stocks traded mixed this morning, with Dow Jones dropping around 20 points on Monday. Following the market opening Monday, the Dow traded down 0.06% to 33,740.98 while the NASDAQ rose 0.08% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 01, 2023

Via Benzinga

Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 01, 2023

Gainers Reunion Neuroscience Inc. (NASDAQ: REUN) gained 95% to $1.33 after the company announced a $13.1 million take-private transaction with MPM BioImpact.

Via Benzinga

7 Value Stocks to Buy for Long-Term Growth ↗

March 26, 2023

If you have the patience to ride out some choppy weather, these value stocks to buy may offer significant upside later.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

This Analyst With 90% Accuracy Rate Raises PT On Chesapeake Energy; Here Are 5 Stock Picks For Last Week From Benzinga's Most Accurate Analysts ↗

November 07, 2022

Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes...

Via Benzinga

This Analyst With 82% Accuracy Rate Boosts PT On Booking Holdings; Here Are 5 Stock Picks For Thursday From Benzinga's Most Accurate Analysts ↗

November 04, 2022

Via Benzinga

Castle Biosciences's Return On Capital Employed Overview ↗

September 01, 2022

According to data from Benzinga Pro, during Q2, Castle Biosciences's (NASDAQ:CSTL) reported sales totaled $34.84 million. Despite a 93.31% increase in earnings, the company posted a loss of $1.65...

Via Benzinga

7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years ↗

May 11, 2022

Finding micro-cap stocks to buy requires a bit of everything, including patience. Today's plan is to pick from the top of the IWC ETF.

Via InvestorPlace

Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday ↗

June 24, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...

Via Benzinga

Castle Biosciences Adds Mental Health Testing Solutions Via AltheaDx Acquisition ↗

April 05, 2022

Castle Biosciences Inc (NASDAQ: CSTL) has agreed to acquire AltheaDx Inc, a commercial-stage molecular diagnostics company,

Via Benzinga

51 Biggest Movers From Yesterday ↗

April 06, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...

Via Benzinga

Castle Biosciences: Q4 Earnings Insights ↗

February 28, 2022

Castle Biosciences (NASDAQ:CSTL) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.